SLSai Mun Leong

Sai Mun Leong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sai Mun Leong has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improved Discrimination of Patients with Breast Cancer from Healthy Controls Using Paper-Based microRNA Expression Profiling of Plasma, Following Precipitation

    by Karen Mei Ling Tan, Siew Peng Tay, Hui Wen Chua, Muhammad Sufyan bin Masroni, Steven Tucker, Evelyn Siew-Chuan Koay, Sai Mun Leong

    To the Editor: Breast cancer is a frequently diagnosed solid tumor in women worldwide (1). MicroRNAs (miRNAs), small noncoding RNAs that regulate protein expression, are potential biomarkers in the diagnosis, prognosis, and prediction of response to treatment in breast cancer (2). We recently reported a paper-based method to extract miRNAs from plasma and circulating tumor cells (3). Here, we applied this method to plasma of patients with breast cancer and age- and gender-matched healthy controls, after treating the plasma with a commercial exosome isolation kit employing a nonspecific precipitation step; we compared the miRNA expression profiles from the plasma with and without the use of the precipitation method. After informed consent and institutional approval, we obtained peripheral blood samples from 9 patients with breast cancer and 9 healthy controls. Plasma was isolated by centrifugation at 3000 g for 10 min and stored at −80 °C. All plasma samples were visually inspected to exclude any discernible hemolysis. Then, 60 μL of Total Exosome Isolation reagent …


  • Paper-Based MicroRNA Expression Profiling from Plasma and Circulating Tumor Cells

    by Sai Mun Leong, Karen Mei-Ling Tan, Hui Wen Chua, Mo-Chao Huang, Wai Chye Cheong, Mo-Huang Li, Steven Tucker, Evelyn Siew-Chuan Koay

    BACKGROUND: Molecular characterization of circulating tumor cells (CTCs) holds great promise for monitoring metastatic progression and characterizing metastatic disease. However, leukocyte and red blood cell contamination of routinely isolated CTCs makes CTC-specific molecular characterization extremely challenging. METHODS: Here we report the use of a paper-based medium for efficient extraction of microRNAs (miRNAs) from limited amounts of biological samples such as rare CTCs harvested from cancer patient blood. Specifically, we devised a workflow involving the use of Flinders Technology Associates (FTA)® Elute Card with a digital PCR-inspired “partitioning” method to extract and purify miRNAs from plasma and CTCs. RESULTS: We demonstrated the sensitivity of this method to detect miRNA expression from as few as 3 cancer cells spiked into human blood. Using this method, background miRNA expression was excluded from contaminating blood cells, and CTC-specific miRNA expression profiles were derived from breast and colorectal cancer patients. Plasma separated out during purification of CTCs could likewise be processed using the same paper-based method for miRNA detection, thereby maximizing the amount of patient-specific information that can be derived from a single blood draw. CONCLUSIONS: Overall, this paper-based extraction method enables an efficient, cost-effective workflow for maximized recovery of small RNAs from limited biological samples for downstream molecular analyses.


  • Open Access

    Prevalence of human endogenous retroviral element associates with Hodgkin's lymphoma incidence rates

    by Wee Hong Woo, Liang Shen, Sai Mun Leong, Evelyn Siew-Chuan Koay